MOSCOW, Russia (AFP) — Pharmaceutical giant AstraZeneca’s Russian branch said Friday it would use part of Russia’s homemade Sputnik V vaccine in further clinical trials. “Today we announce a clinical trial programme to assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University, and Sputnik V, developed by Russian Gamaleya Research institute,” AstraZeneca said in a statement published on its website in English and Russian. The pharmaceutical company said […]